Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design
Open Access
- 28 May 2026
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 56, 104201
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health and Care Research
This publication has 22 references indexed in Scilit:
- Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy?Clinical Oncology, 2026
- The POINTER-PC Study-determining Optimal Radiotherapy for Pelvic Nodal Recurrence in Prostate CancerClinical Oncology, 2025
- Best Practice for Patient-centred Radiotherapy in Clinical Trials and Beyond—A National Multidisciplinary ConsensusClinical Oncology, 2024
- Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled TrialsClinical Oncology, 2023
- Prospective randomized clinical studies involving reirradiation: update of a systematic reviewStrahlentherapie und Onkologie, 2023
- Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is RecruitingClinical Oncology, 2023
- Complex Clinical Decision-Making Process of Re-IrradiationClinical Oncology, 2020
- Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysisJournal of Neuro-Oncology, 2018
- Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic reviewRadiotherapy and Oncology, 2017
- Patients' experience of decision-making and receiving information during radiation therapy: A qualitative studyEuropean Journal of Oncology Nursing, 2017